Molecular Insight Pharmaceuticals has priced the initial public offering (IPO) of 5 million shares of its common stock at $14 per share.
The Cambridge, MA-based company's common stock will trade on the Nasdaq Global Market under the trading symbol "MIPI."
By AuntMinnie.com staff writers
February 2, 2007
Related Reading
Molecular Insight starts phase I neuroendocrine cancer trial, June 22, 2006
Molecular Insight begins phase II clinical trial, March 27, 2006
MDS Nordion, Molecular Insight Pharmaceutical partner, February 16, 2006
Molecular Insight fills executive ranks, July 21, 2005
Molecular Insight hires new vice presidents, June 1, 2005
Copyright © 2007 AuntMinnie.com